Minimally Invasive Lung Adenocarcinoma
5 clinical trials · Condition
◉ Watch Minimally Invasive Lung Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer (NCT03110978) | M.D. Anderson Cancer Center | 2017-06-26 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT01386385) | National Cancer Institute (NCI) | 2011-06-20 |
| Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT00334815) | National Cancer Institute (NCI) | 2006-06-15 |
| Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer (NCT00126581) | National Cancer Institute (NCI) | 2005-08-15 |
Track Minimally Invasive Lung Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.